Organic electroluminescent materials and devices

US10033000B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10033000-B2
Application numberUS-201414521281-A
CountryUS
Kind codeB2
Filing dateOct 22, 2014
Priority dateNov 15, 2013
Publication dateJul 24, 2018
Grant dateJul 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

According to one embodiment, a compound comprising a ligand L A of Formula I is described. In the structure of Formula I, A 1 through A 8 are independently carbon or nitrogen, with at least one being nitrogen; X 1 is selected from the group consisting of O, S, and Se; X 2 and X 3 are independently selected from the group consisting of C, N, O, P, and S; ring A is a 5- or 6-membered heterocyclic ring bonded to ring B through a X 2 —C bond and bonded to M through a metal-carbene bond; any adjacent substitutions in R 1 and R 2 are optionally linked together to form a ring; the ligand L A is coordinated to a metal M; and the ligand L A is optionally linked with other ligands to comprise up to a hexadentate ligand. Formulations and devices, such as an OLEDs, that include the compound comprising ligand L A of formula I are also described.

First claim

Opening claim text (preview).

We claim: 1. A compound having a formula M(L A ) m (L B ) n , having a structure: wherein M is a metal; wherein m is an integer from 1 to the maximum number of ligands that may be coordinated to the metal M; m+n is the maximum number of ligands that may be coordinated to the metal M; wherein each A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , and A 8 is independently carbon or nitrogen; wherein at least one of A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , or A 8 is nitrogen; wherein X 1 is selected from the group consisting of O, S, and Se; wherein X 2 and X 3 each independently comprise an atom selected from the group consisting of C, N, O, P, and S; wherein ring A is bonded to ring B through a X 2 —C bond; wherein ring A is a 5- or 6-member heterocyclic ring; wherein R 1 and R 2 each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein adjacent substitutions in R 2 are optionally linked together to form a phenyl or pyridyl ring fused to ring A, and the phenyl or pyridyl ring may be further substituted; wherein R 1 and R 2 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein M is coordinated to ring A through a metal-carbene bond and to ring B through a M-C bond; and wherein the ligand L A is optionally linked with one or two L B ligands to comprise a tetradentate or hexadentate ligand; and wherein ligand L B is selected from the group consisting of: 2. The compound of claim 1 , wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 3. The compound of claim 1 , wherein M is Ir. 4. The compound of claim 1 , wherein X 1 is O. 5. The compound of claim 1 , wherein only one of A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , or A 8 is nitrogen. 6. The compound of claim 1 , wherein each one of A 1 , A 2 , A 3 , and A 4 is carbon. 7. The compound of claim 1 , wherein each one of A 1 , A 2 , A 3 , and A 4 is carbon, and exactly one of A 5 , A 6 , A 7 , or A 8 is nitrogen. 8. The compound of claim 1 , wherein R 2 forms a phenyl or pyridyl ring fused to ring A; and wherein the phenyl or pyridyl ring may be further substituted. 9. The compound of claim 1 , wherein ring A is selected from the group consisting of: wherein the wave line indicates the bond to ring B; wherein R 3 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. 10. The compound of claim 1 , wherein the ligand L A is: wherein R 3 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. 11. The compound of claim 1 , wherein L A is selected from the group consisting of: 12. A formulation comprising the compound of claim 1 . 13. The compound of claim 1 , wherein the ligand L A is: wherein R 10 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. 14. The compound of claim 13 , wherein the ligand L A is: 15. A compound having a structure selected from the group consisting of: wherein m and n are integers and m+n=3; wherein each A 5 , A 6 , A 7 , and A 8 is independently carbon or nitrogen; wherein at least one of A 5 , A 6 , A 7 , or A 8

Assignees

Inventors

Classifications

  • Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • Iridium compounds · CPC title

  • the oxygen-containing ring being five-membered · CPC title

  • containing organic luminescent materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10033000B2 cover?
According to one embodiment, a compound comprising a ligand L A of Formula I is described. In the structure of Formula I, A 1 through A 8 are independently carbon or nitrogen, with at least one being nitrogen; X 1 is selected from the group consisting of O, S, and Se; X 2 and X 3 are independently selected from the group consisting of C, N, O, P, and S; ring A i…
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).